ClinicalTrials.gg
Status unknownNCT02978079Updated Jan 11, 2021

Pupillometry in Horner's Syndrome

An interventional study of Automated pupillometry in Horner's Syndrome, Stroke and Dissection Carotid Artery, sponsored by University of Zurich. Status unknown at 1 site in Switzerland. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2021-01-11.

Sponsored by University of Zurich · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Jan 2021), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
135
Allocation
Not applicable
Ages
18 Years to 60 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 26 studies in Stroke by University of Zurich — 6 open to participants now, 8 under way, none of them phase 3. Stroke · University of Zurich.

Planned enrollment
Largest of 13
135 · median 49
Started
2017
with 4 others
No phase
9 of 26
2 open now
Registered
11th of 26
by date

Among the 26 studies in Stroke by University of Zurich, this one has the largest planned enrollment of the 13 interventional ones that give a count, is one of 5 that started in 2017, is one of 9 with no phase, and was the 11th registered.

Stroke

8,269 studies on the registry are indexed under Stroke; 2,062 are open to participants now.

Browse Stroke studies →

Open to participants now

6 of the 26 studies in Stroke by University of Zurich are open now, in 1 country. Recruiting first, the newest first:

1 more — sign in →

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,419 Stroke studies recruiting now, 695 (49%) set no upper age limit and 283 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 60 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 26 studies in Stroke by University of Zurich, or all of them as a file.
02

Study summary

Horner's syndrome (HS) is a result of interruption of the sympathetic innervation to the eye and ocular adnexa, which can occur due to carotid artery dissection (CAD), along which the sympathetic nerve fibers travel to reach the eye. Dissection of the carotid artery is one of the etiologies for ischemic stroke in young patients.

In our current study, we will explore the diagnostic accuracy of automated binocular pupillometry in the diagnosis or HS, and its potential in identifying dissection of the carotid artery in patients of young age who suffer ischemic stroke.

03

Conditions studied

  • Horner's Syndrome
  • Stroke
  • Dissection Carotid Artery

Browse trials for

04

Who can participate

Ages eligible
18 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults 60 years of age or younger
  • Acute stroke (less than 72 hours from admission)
  • as documented by signature (Appendix Informed Consent Form)
  • Ability to understand the study information and consent form

Exclusion criteria

Exclusion Criteria:

  • known history of HS
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc.
  • Medications affecting pupillary response
  • History of ocular surgery affecting the pupil
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
135 participants (estimated)

Study arms

  • Experimental
    Pupillometry in stroke patients

    All eligible patients will undergo pupillometry test for the finding of Horner's syndrome

    Device: Automated pupillometry

Interventions

  • DeviceAutomated pupillometry

    Automated pupillometry will be performed in patients with acute stroke with the intention of diagnosing Horner's syndrome

06

What researchers measure

Primary outcomes

  1. Finding of pupillary dilation lag using pupillometry in patients with acute stroke due to carotid artery dissection

    Time frame: 1 day of initial visit

07

Study locations

1 of 1 sites recruiting
  • Ophthalmology Department, University Hospital Zurich
    Zurich, CH-8091, Switzerland
    Recruiting
    • Konrad P Weber, MD · ContactKONRAD.WEBER@USZ.CH · 0041442555549
    • Konrad P Weber, MD · Principal investigator
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Feb 2017 (actual). Primary completion is estimated for Dec 2021, 58 months after the start.

Of 3,119 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 58 months is above that.

Counting every sponsor, half of 3,263 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 28, 2016
First posted
Nov 30, 2016
StartActual
Feb 15, 2017
Primary completionEst.
Dec 31, 2021
CompletionEst.
Dec 31, 2022
Last update
Jan 11, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 11, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02978079
Responsible party
Konrad Peter Weber (Principal Investigator, University of Zurich) — Principal investigator
First posted
Nov 30, 2016
Start date
Feb 15, 2017
Primary completion
Dec 31, 2021 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
Jan 11, 2021

Study contacts

Konrad P Weber, MD
principal investigator · Ophthalmology Department, University Hospital Zurich

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Jan 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion